Home / AVCRF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AVCRF make money? Does AVCRF have pricing power? What's the Earnings Whisper? Will AVCRF profit more as the business scales? What is AVCRF's management track record? Is AVCRF's current price justified?

Avricore Health Inc.

$0 -$0.03 (-97.50%)

OTC · 14 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0.04

Year Range

$0$0.08

Market Cap

81.03K

AVG Volume

36.53K

Trailing/Forward PE

-3.41/-

PEG ratio

0.15

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (CAD)

AVCRF Revenue (CAD) by year
Period	Revenue (CAD)
2025	533.91K
2024	4.79M
2023	3.49M
2022	1.77M
2021	122.81K
2020	33.03K
2019	33K
2018	226.44K
2017	537.71K
2016	1.01M

Net Income (CAD)

AVCRF Net Income (CAD) by year
Period	Net Income (CAD)
2025	-1.86M
2024	-668.98K
2023	-701.22K
2022	-824.88K
2021	-1.71M
2020	-1.17M
2019	-2.11M
2018	-4.14M
2017	-2.74M
2016	-2.61M

Operating Income (CAD)

AVCRF Operating Income (CAD) by year
Period	Operating Income (CAD)
2025	-1.37M
2024	145.4K
2023	-691.08K
2022	-809.86K
2021	-1.67M
2020	-853.49K
2019	-1.6M
2018	-2.88M
2017	-1.99M
2016	-2.33M

EBITDA (CAD)

AVCRF EBITDA (CAD) by year
Period	EBITDA (CAD)
2025	-1.23M
2024	579.2K
2023	-281.15K
2022	-637.14K
2021	-1.65M
2020	-908K
2019	-1.39M
2018	-2.44M
2017	-2.72M
2016	-2.61M

Cash Flows (CAD)

AVCRF Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2025	-898.25K
2024	799.27K
2023	-386.46K
2022	-1.64M
2021	-1.37M
2020	-1.22M
2019	-686.41K
2018	-1.85M
2017	-1.77M
2016	-2.07M

EPS (CAD)

AVCRF EPS (CAD) by year
Period	EPS (CAD)
2025	-0.02
2024	-0.01
2023	-0.01
2022	-0.01
2021	-0.02
2020	-0.02
2019	-0.05
2018	-0.12
2017	-0.14
2016	-0.18

Expenses (CAD)

AVCRF Expenses (CAD) by year
Period	Expenses (CAD)
2025	1.63M
2024	2.06M
2023	3M
2022	2.45M
2021	1.86M
2020	848.16K
2019	1.37M
2018	2.38M
2017	2.19M
2016	2.53M

Cash & Debt (CAD)

AVCRF Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2025	237.72K
2024	1.14M
2023	286.57K
2022	630.53K
2021	2.26M
2020	302.71K
2019	13.8K
2018	84.44K
2017	559.73K
2016	427.48K

Debt ratios

AVCRF Debt ratios by year
Period	Debt ratios
2025	0.15
2024	0.57
2023	0.07
2022	0.13
2021	0.35
2020	-0.09
2019	-0
2018	0.01

Margins

AVCRF Margins by year
Period	Margins
2025	44.68%
2024	39.27%
2023	32.27%
2022	25.83%
2021	24.85%
2020	52.92%
2019	43.93%
2018	16.8%
2017	45.91%
2016	29.87%

Return on Capital

AVCRF Return on Capital by year
Period	Return on Capital
2025	-477.47%
2024	-34%
2023	-34.9%
2022	-42%
2021	-77.75%
2020	164.41%
2019	452.38%
2018	-466.93%
2017	-109.55%
2016	-136.28%

Shares Outstanding

AVCRF Shares Outstanding by year
Period	Shares Outstanding
2025	101.29M
2024	100.09M
2023	99.64M
2022	97.86M
2021	93.82M
2020	83.1M
2019	52.53M
2018	41.67M
2017	28.33M
2016	15M

Book Value Per Share (CAD)

AVCRF Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2025	0
2024	0.02
2023	0.02
2022	0.02
2021	0.02
2020	-0.01
2019	-0.01
2018	0.02
2017	0.09
2016	0.13

Total Assets (CAD)

AVCRF Total Assets (CAD) by year
Period	Total Assets (CAD)
2025	562.66K
2024	2.3M
2023	2.54M
2022	2.57M
2021	2.28M
2020	440.09K
2019	208.4K
2018	1.2M
2017	2.9M
2016	2.28M

Employee Count

AVCRF Employee Count by year
Period	Employee Count
2024	1
2023	1
2022	1
2018	2
2017	9
2016	8
2013	350
2012	350
2011	3
2010	3

PE Ratio

AVCRF PE Ratio by year
Period	PE Ratio
Jun 25	35.5
Jun 25	56.14
May 25	59.85
May 25	42.87
May 25	47.54
May 25	37.64
May 25	66.88
Apr 25	41.57
Apr 25	41.52
Apr 25	42.82
Apr 25	47.99
Mar 25	64.47
Mar 25	42.21
Mar 25	40.94
Mar 25	22.31
Feb 25	46.62
Feb 25	57.54
Feb 25	57.4
Feb 25	57.82
Jan 25	61.39
Jan 25	60.61
Jan 25	66.15
Jan 25	53.05
Jan 25	57.9

Free Cash Flow Yield

AVCRF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-946.49%
Sep 26	-949.04%
Aug 26	-30.22%
Aug 26	-30.52%
Aug 26	-30.28%
Aug 26	-30.14%
Jul 26	-29.98%
Jul 26	-21.85%
Jul 26	-15.51%
Jul 26	-11.19%
Jul 26	-17.98%
Jun 26	-20.72%
Jun 26	-13.73%
Jun 26	-13.86%
Jun 26	-13.92%
May 26	-20.55%
May 26	-19.78%
May 26	-14.8%
May 26	-4.77%
May 26	-4.42%
Apr 26	-3.16%
Apr 26	-3.17%
Apr 26	-3.18%
Apr 26	-4.04%
Mar 26	-3.18%
Mar 26	-3.39%
Mar 26	-3.57%
Mar 26	-3.13%
Feb 26	-3.49%
Feb 26	-3.19%
Feb 26	-3.61%
Feb 26	-3.66%
Jan 26	-4.27%
Jan 26	-2.73%
Jan 26	-2.87%
Jan 26	-5.94%
Jan 26	-5.91%
Dec 25	6.19%
Dec 25	3.9%
Dec 25	4.75%
Dec 25	5.84%
Nov 25	5.28%
Nov 25	5.23%
Nov 25	4.39%
Nov 25	4.09%
Oct 25	4.09%
Oct 25	4.93%
Oct 25	2.98%
Oct 25	3.35%
Oct 25	4%
Sep 25	3.56%
Sep 25	3.63%
Sep 25	8.92%
Sep 25	8.07%
Aug 25	7.99%
Aug 25	10.4%
Aug 25	9.44%
Aug 25	7.53%
Aug 25	6.46%
Jul 25	6.12%
Jul 25	8.78%
Jul 25	9.29%
Jul 25	13.7%
Jun 25	16.22%
Jun 25	13.51%
Jun 25	9.61%
Jun 25	6.08%
May 25	5.7%
May 25	7.96%
May 25	7.18%
May 25	9.07%
May 25	5.1%
Apr 25	8.21%
Apr 25	8.22%
Apr 25	7.97%
Apr 25	7.11%
Mar 25	5.29%
Mar 25	8.08%
Mar 25	8.34%
Mar 25	15.3%
Feb 25	7.32%
Feb 25	5.93%
Feb 25	5.95%
Feb 25	5.9%
Jan 25	5.56%
Jan 25	5.63%
Jan 25	5.16%
Jan 25	6.43%
Jan 25	5.89%
Dec 24	1.62%
Dec 24	1.63%
Dec 24	1.32%
Dec 24	1.1%
Nov 24	1.79%
Nov 24	1.55%
Nov 24	1.37%
Nov 24	0.61%
Nov 24	0.63%
Oct 24	0.61%
Oct 24	0.53%

Price to Sales

AVCRF Price to Sales by year
Period	Price to Sales
Sep 26	0.78
Sep 26	0.78
Aug 26	24.4
Aug 26	24.16
Aug 26	24.35
Aug 26	24.46
Jul 26	24.59
Jul 26	33.74
Jul 26	47.54
Jul 26	15.03
Jul 26	9.35
Jun 26	8.12
Jun 26	12.25
Jun 26	12.14
Jun 26	12.08
May 26	8.19
May 26	8.5
May 26	11.37
May 26	2.88
May 26	3.1
Apr 26	4.34
Apr 26	4.33
Apr 26	4.31
Apr 26	3.4
Mar 26	4.31
Mar 26	4.05
Mar 26	3.84
Mar 26	4.37
Feb 26	3.92
Feb 26	4.3
Feb 26	3.8
Feb 26	3.75
Jan 26	3.21
Jan 26	5.02
Jan 26	4.78
Jan 26	2.31
Jan 26	2.32
Dec 25	1.21
Dec 25	1.92
Dec 25	1.57
Dec 25	1.28
Nov 25	1.42
Nov 25	1.43
Nov 25	1.7
Nov 25	1.83
Oct 25	1.83
Oct 25	1.52
Oct 25	2.51
Oct 25	2.24
Oct 25	1.87
Sep 25	2.1
Sep 25	2.06
Sep 25	1.68
Sep 25	1.86
Aug 25	1.88
Aug 25	1.44
Aug 25	1.59
Aug 25	1.99
Aug 25	2.32
Jul 25	2.45
Jul 25	1.71
Jul 25	1.62
Jul 25	1.1
Jun 25	1.03
Jun 25	1.24
Jun 25	0.78
Jun 25	1.23
May 25	1.31
May 25	0.94
May 25	1.04
May 25	0.82
May 25	1.46
Apr 25	0.91
Apr 25	0.91
Apr 25	0.94
Apr 25	1.05
Mar 25	1.41
Mar 25	0.92
Mar 25	0.89
Mar 25	0.49
Feb 25	1.02
Feb 25	1.26
Feb 25	1.25
Feb 25	1.26
Jan 25	1.34
Jan 25	1.32
Jan 25	1.45
Jan 25	1.16
Jan 25	1.27
Dec 24	1.33
Dec 24	1.33
Dec 24	1.63
Dec 24	1.95
Nov 24	1.21
Nov 24	1.39
Nov 24	1.57
Nov 24	3.56
Nov 24	3.42
Oct 24	3.56
Oct 24	4.06

EV/EBITDA

AVCRF EV/EBITDA by year
Period	EV/EBITDA
Sep 25	20.51
Sep 25	23.15
Aug 25	23.43
Aug 25	16.92
Aug 25	19.11
Aug 25	25.17
Aug 25	30.09
Jul 25	32.03
Jul 25	20.9
Jul 25	19.52
Jul 25	11.72
Jun 25	6.54
Jun 25	8.24
Jun 25	5.02
Jun 25	8.74
May 25	9.41
May 25	6.35
May 25	7.19
May 25	5.4
May 25	10.67
Apr 25	6.11
Apr 25	6.1
Apr 25	6.34
Apr 25	7.27
Mar 25	10.24
Mar 25	6.23
Mar 25	6
Mar 25	2.64
Feb 25	7.02
Feb 25	8.99
Feb 25	8.96
Feb 25	9.04
Jan 25	9.68
Jan 25	9.54
Jan 25	10.54
Jan 25	8.18
Jan 25	9.06
Dec 24	11.53
Dec 24	11.5
Dec 24	14.41
Dec 24	17.5
Nov 24	10.36
Nov 24	12.08
Nov 24	13.83
Nov 24	32.87
Nov 24	31.55
Oct 24	32.84
Oct 24	37.69
Oct 24	37.58
Oct 24	46.6
Sep 24	191.86
Sep 24	182.29
Sep 24	182.53
Sep 24	218.74
Aug 24	264.4
Aug 24	269.46
Aug 24	284.86
Aug 24	211.74
Aug 24	285.57
Jul 24	273.25
Jul 24	234.13
Jul 24	159.12
Jul 24	147.51

Price/Operating Cashflow

AVCRF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Dec 25	9.33
Dec 25	14.78
Dec 25	12.14
Dec 25	9.88
Nov 25	10.93
Nov 25	11.03
Nov 25	13.14
Nov 25	14.11
Oct 25	14.1
Oct 25	11.71
Oct 25	19.34
Oct 25	17.24
Oct 25	14.43
Sep 25	16.23
Sep 25	15.88
Sep 25	8.42
Sep 25	9.3
Aug 25	9.4
Aug 25	7.22
Aug 25	7.95
Aug 25	9.98
Aug 25	11.63
Jul 25	12.27
Jul 25	8.55
Jul 25	8.09
Jul 25	5.48
Jun 25	4.91
Jun 25	5.89
Jun 25	4.04
Jun 25	6.39
May 25	6.81
May 25	4.88
May 25	5.41
May 25	4.28
May 25	7.61
Apr 25	4.73
Apr 25	4.73
Apr 25	4.88
Apr 25	5.46
Mar 25	7.34
Mar 25	4.81
Mar 25	4.66
Mar 25	2.54
Feb 25	5.31
Feb 25	6.55
Feb 25	6.53
Feb 25	6.58
Jan 25	6.99
Jan 25	6.9
Jan 25	7.53
Jan 25	6.04
Jan 25	6.59
Dec 24	7.01
Dec 24	6.99
Dec 24	8.6
Dec 24	10.29
Nov 24	6.37
Nov 24	7.32
Nov 24	8.28
Nov 24	18.75
Nov 24	18.03
Oct 24	18.74
Oct 24	21.41
Oct 24	21.35
Oct 24	26.31
Sep 24	21.72
Sep 24	20.66
Sep 24	20.69
Sep 24	24.67
Aug 24	29.69
Aug 24	30.25
Aug 24	31.94
Aug 24	23.9
Aug 24	32.02
Jul 24	30.67
Jul 24	26.37
Jul 24	18.11
Jul 24	16.84
Jun 24	26.5
Jun 24	26.92
Jun 24	45.7
May 24	39.08
May 24	43.22
Apr 24	24.21
Apr 24	24.4
Apr 24	24.04
Apr 24	34.77
Mar 24	39.05
Feb 24	39.63
Feb 24	34.68
Feb 24	34.61
Feb 24	34.55
Feb 24	39.3
Jan 24	39.25
Jan 24	39.18
Jan 24	34.41
Jan 24	48.77
Dec 23	37.4

Price to Book

AVCRF Price to Book by year
Period	Price to Book
Sep 26	0.57
Sep 26	0.57
Aug 26	17.99
Aug 26	17.81
Aug 26	17.95
Aug 26	18.03
Jul 26	18.13
Jul 26	24.87
Jul 26	35.05
Jul 26	20.62
Jul 26	12.83
Jun 26	11.14
Jun 26	16.8
Jun 26	16.65
Jun 26	16.57
May 26	11.23
May 26	11.67
May 26	15.59
May 26	4.27
May 26	4.61
Apr 26	6.44
Apr 26	6.42
Apr 26	6.4
Apr 26	5.04
Mar 26	6.4
Mar 26	6.01
Mar 26	5.7
Mar 26	6.49
Feb 26	5.82
Feb 26	6.37
Feb 26	5.63
Feb 26	5.56
Jan 26	4.76
Jan 26	7.46
Jan 26	7.1
Jan 26	3.43
Jan 26	3.44
Dec 25	2.3
Dec 25	3.64
Dec 25	2.99
Dec 25	2.43
Nov 25	2.69
Nov 25	2.72
Nov 25	3.24
Nov 25	3.48
Oct 25	3.47
Oct 25	2.89
Oct 25	4.76
Oct 25	4.25
Oct 25	3.56
Sep 25	4
Sep 25	3.91
Sep 25	3.53
Sep 25	3.9
Aug 25	3.94
Aug 25	3.03
Aug 25	3.33
Aug 25	4.18
Aug 25	4.87
Jul 25	5.14
Jul 25	3.58
Jul 25	3.39
Jul 25	2.3
Jun 25	2.5
Jun 25	3.01
Jun 25	1.47
Jun 25	2.33
May 25	2.48
May 25	1.78
May 25	1.97
May 25	1.56
May 25	2.77
Apr 25	1.72
Apr 25	1.72
Apr 25	1.77
Apr 25	1.99
Mar 25	2.67
Mar 25	1.75
Mar 25	1.7
Mar 25	0.92
Feb 25	1.93
Feb 25	2.38
Feb 25	2.38
Feb 25	2.4
Jan 25	2.54
Jan 25	2.51
Jan 25	2.74
Jan 25	2.2
Jan 25	2.4
Dec 24	2.62
Dec 24	2.61
Dec 24	3.21
Dec 24	3.84
Nov 24	2.38
Nov 24	2.73
Nov 24	3.09
Nov 24	7
Nov 24	6.73
Oct 24	6.99
Oct 24	7.99

No video analysis for this stock yet. Request one from our team.

News: AVCRF

globenewswire.com · 1 Sep 2026

HealthTab™ Programme Expands Nationally Across England

VANCOUVER, British Columbia, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that NHS England has confirmed the national expansion of the Barts Health pharmacy cholesterol testing programme powered by Avricore's HealthTab™ platform.

globenewswire.com · 28 Aug 2026

Avricore Grants Options

VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) today announces that the Company's board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,300,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.06 per common share.

globenewswire.com · 20 Aug 2026

HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK

VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott, a global healthcare company, to supply and distribute Abbott's point-of-care testing products through the HealthTab™ platform in the UK.

globenewswire.com · 17 Jun 2026

Avricore Health Closes $1.254 Million Financing

VANCOUVER, British Columbia, June 17, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces that, further to its news release dated May 20, 2026, the Company has closed its non-brokered private placement for gross proceeds of $1,254,000 by issuing 25,080,000 Units at $0.05 per Unit on June 16, 2026.